Oral fingolimod reduces glutamate-mediated intracortical excitability in relapsing–remitting multiple sclerosis

Autor: Landi, D., Vollaro, S., Pellegrino, G., Mulas, D., Ghazaryan, A., Falato, E., Pasqualetti, P., Rossini, P.M., Filippi, M.M.
Zdroj: In Clinical Neurophysiology January 2015 126(1):165-169
Databáze: ScienceDirect